Randomised double-blind comparison of oral gatifloxacin and co-amoxiclav for acute exacerbation of chronic bronchitis

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 22, Issue 3, 2003, Pages 144-150

  Soler M ^a   Lode, H ^b   Baldwin, R ^c   Levine, J H A ^d   Schreurs, A J M ^e   Van Noord, J A ^f   Maesen, F P V ^f   Zehreron, M ^g  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c The Surgery ^*  (United Kingdom)

^d The Surgery   (United Kingdom)

^e JEROEN BOSCH HOSPITAL   (Netherlands)

^f NONE   (Netherlands)

^g GRÜNENTHAL GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; GATIFLOXACIN;

ADULT; ANTIMICROBIAL THERAPY; ARTICLE; CHRONIC BRONCHITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0037365588     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-003-0897-3     Document Type: Article

References (31)

1. Ball P, Make B (1998) Acute exacerbations of chronic bronchitis. An international comparison. Chest 113:1995-2045
2. Sethi S (1999) Infectious exacerbations of chronic bronchitis: diagnosis and management. J Antimicrob Chemother 43 (Suppl A):97-105
3. Anthonisen NR, Manfreda J, Warren CPW, Hershifield ES, Harding GKM, Nelson NA (1987) Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 106:196-204
4. Ball P (1995) Epidemiology and treatment of chronic bronchitis and its exacerbations. Chest 108 (Suppl):43-52
5. Hill SL, Pye A, Johnson MM, Munday C, Stockley RA (1997) A role for Haemophilus parainfluenzae in chronic lung disease. Am J Respir Crit Care Med 155:105
6. Ramirez J (1999) Penicillin-resistant pneumococci: new-generation fluoroquinolones and lower respiratory tract infections. Hosp Med 35:43-49
7. Langan CE, Cranfield R, Breisch S, Pettit R (1997) Randomized, double-blind study of grepafloxacin versus amoxycillin in patients with acute bacterial exacerbation of chronic bronchitis. J Antimicrob Chemother 40:63-72
8. DeAbate CA, Henry D, Bensch G, Jubran A, Chodosh S, Harper L, Tipping D, Talbot G (1998) Sparfloxacin vs. ofloxacin in the treatment of acute bacterial exacerbation of bronchitis - a multicenter, double-blind, randomized, comparative study. Chest 144:120-130
9. DeAbate CA, Myers D, Henry D, Upchurch J, Lecara G, Giguere G, Collins JJ (1999) Efficacy and tolerability of once-daily grepafloxacin compared with clarithromycin in the treatment of acute bacterial exacerbation of chronic bronchitis. Clin Drug Invest 17:21-31
10. Shah PM, Maesen FPV, Dolmann A, Vetter N, Fiss E, Wesch R (1999) Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis: results of a randomized, double-blind study. J Antimicrob Chemother 43:529-539
11. Niederman MS (2000) Antibiotic therapy of exacerbations of chronic bronchitis. Semin Respir Infect 15:59-70
12. Perry CM, Barman Balfour JA, Lamb HM (1999) Gatifloxacin. Drugs 58:683-696
13. Bauernfeind A (1997) Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin. J Antimicrob Chemother 40:639-651
14. th Interscience Conference on Antimicrobial Agents and Chemotherapy (abstract)
15. Honeybourne D, Banerjee D, Andrews JM, Wise R (2001) Concentrations of gatifloxacin in plasma and pulmonary compartments following a single 400 mg oral dose in patients undergoing fibre-optic bronchoscopy. J Antimicrob Chemother 48:63-66
16. Chodosh S (1991) Treatment of chronic bronchitis: state of the art. Am J Med 91(Suppl 6A):87-92
17. Beam TR, Gilbert DN, Kunin CM (eds) with modification by a European Working Party (1993) European guidelines for the clinical evaluation of anti-infective drug products. Published for the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), pp 1-31
18. American Thoracic Society (1962) Chronic bronchitis, asthma, and pulmonary emphysema: a statement by the Committee on Diagnostic Standards for Nontuberculosis Respiratory Diseases. Am Rev Respir Dis 85:762-768
19. Farrington CP, Manning G (1990) Test statistics and a sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference of non-unity relative risk. Stat Med 9:1447-1454
20. Hollander M, Woolfe DA (1973) Nonparametric statistical methods. Wiley, New York Chichester Brisbane Toronto Singapore
21. DeAbate CA, Fogarty C, Grooms E, Pierce PF (1998) Efficacy and safety of gatifloxacin in acute exacerbation of chronic bronchitis. Clin Infect Dis 27:953
22. DeAbate CA, McIvor RA, McElvaine P, Skuba K, Pierce PF (1999) Gatifloxacin vs. cefuroxime axetil in patients with acute exacerbations of chronic bronchitis. J Respir Dis 20 (Suppl 11):23-29
23. th Interscience Conference on Antimicrobial Agents and Chemotherapy (abstract)
24. Stahlmann R (2002) Clinical toxicological aspects of fluoroquinolones. Toxicol Lett 127:269-277
25. Wolfson JS, Hooper DC (1989) Fluoroquinolone antimicrobial agents. Clin Microbiol Rev 2:378-424
26. Ball P, Tillotson G (1995) Tolerability of fluoroquinolone antibiotics. Past present and future. Drug Saf 13:343-358
27. Lietman PS (1995) Fluoroquinolone toxicities. An update. Drugs 49:159-163
28. Hayem G, Carbon C (1995) A reappraisal of quinolone tolerability: the experience of their musculoskeletal effects. Drug Saf 13:338-342
29. Blum MD, Graham DJ, McCloskey CA (1994) Temafloxacin syndrome: review of 95 cases. Clin Infect Dis 18:946-950
30. Wilson R, Kubin R, Ballin I, Deppermann K-M, Bassaris HP, Leophonte P, Schreurs Ad JM, Tortes A, Sommerauer B (1999) Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis. J Antimicrob Chemother 44:501-513
31. Shah PM, Maesen FP, Dolmann A, Vetter N, Fiss E, Wesch R (1999) Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis: results of a randomized, double-blind study. J Antimicrob Chemother 43:529-539